Product Reports Resources Pricing Login Book a demo

RxREVU

Biotech & Life Sciences · Denver, United States · Founded 2013

Helps patients and providers save money on prescriptions by identifying the most effective medication at the best possible cost MoreLess

RxRevu operates in the healthcare technology sector, focusing on providing real-time prescription benefit data to healthcare providers. The company serves hospitals, health systems, and electronic health record (EHR) vendors across the United States. RxRevu's core product is a price transparency network that delivers patient-specific cost and coverage information at the point of care. This service helps healthcare providers make informed prescribing decisions, ultimately aiming to improve patient outcomes and reduce healthcare costs. The business model revolves around partnerships with healthcare organizations and EHR vendors, generating revenue through subscription fees and data-sharing agreements. By integrating its solution into native EHR workflows, RxRevu ensures that providers have seamless access to critical cost and coverage data during patient consultations. The company has been recognized for its rapid growth and innovation, as evidenced by its inclusion in the Inc. 5000 list of fastest-growing private companies.

Keywords: price transparency, healthcare technology, prescription benefit data, EHR integration, patient-specific information, cost reduction, value-based care, healthcare providers, real-time data, subscription model.

Company overview

RxREVU company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2013
Headquarters
Denver, United States
Employees
43
Open positions
None listed
Dealroom signal
62.4
Investment activity
1 companies · latest Mar 2026
Capital deployed
Preferred round
MERGER
client focusb2btechnologyArtificial IntelligencetechnologyDeep TechtechnologyMachine Learningsub industryPharmaceuticalsub industryHealth Platformbusiness modelSaaSindustryHealthsectorAnalyticssectorPredictive AnalyticssectorBiotechnologysectorUser BehaviorsectorNeurologysectorPatient Care

Valuation & funding

RxREVU funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
MERGEROther financing Mar 2026 $0 DoseSpot
LATE VCEquity / VC Jul 2021 $8M $80M JAZZ Venture Partners
SERIES BEquity / VC Jan 2021 $7M $80M JAZZ Venture Partners
SERIES AEquity / VC Jun 2019 $16M $64M UnityPoint Health · UCHealth · Presbyterian Healthcare Services · JAZZ Venture Partners
EARLY VCEquity / VC Jan 2017 $4.7M $19M Undisclosed
SEEDEquity / VC Mar 2016 Undisclosed
SEEDEquity / VC Apr 2015 Undisclosed
SEEDEquity / VC Jul 2014 Undisclosed
EARLY VCEquity / VC Dec 2013 Undisclosed
Showing 9 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $9.1M 0% 40
2025 $9.1M 0% 70
2024 $9.1M 0% 61
2023 $9.1M +4.2% 69
2022 $8.8M 0% 78
2021 $8.8M +90.2% 78
2020 $4.6M 54
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

RxREVU website traffic

Latest recorded traffic for RxREVU is 240 monthly website visits, down 87.4% over the last three months. RxREVU's team declined 38.6% over the past year.

Latest monthly visits240 3-month web change-87.4% 1-year team growth-38.6%
Monthly website visits59 observations · Apr 2016–Apr 2023
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

RxREVU compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Capital deployed

RxREVU investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

Talent graph

RxREVU's talent

Book a demo to see the people
Team profiled 22 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

15 investors on RxREVU's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 5 investors entered at this stage
UnityPoint Health
UCHealth
Presbyterian Healthcare Services
JAZZ Venture Partners
Froedtert Health
Other known 10 additional known investors
DoseSpot
Allumia Ventures
FirstTracks Ventures
Interra Health
MemorialCare Innovation Fund
Providence Ventures
Small Business Innovation Research
Summation Health Ventures
UnityPoint Health Ventures
Upslope Ventures

Global footprint

Where RxREVU has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about RxREVU

Recent press, funding announcements, and product moves mentioning RxREVU — open to read from the original sources.

See all news

Market sentiment

What the market is saying about RxREVU

An AI-synthesized read of the highest-engagement posts about RxREVU on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See RxREVU’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.